636 related articles for article (PubMed ID: 22388737)
21. Proteome dynamics at broken replication forks reveal a distinct ATM-directed repair response suppressing DNA double-strand break ubiquitination.
Nakamura K; Kustatscher G; Alabert C; Hödl M; Forne I; Völker-Albert M; Satpathy S; Beyer TE; Mailand N; Choudhary C; Imhof A; Rappsilber J; Groth A
Mol Cell; 2021 Mar; 81(5):1084-1099.e6. PubMed ID: 33450211
[TBL] [Abstract][Full Text] [Related]
22. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
Smith LM; Willmore E; Austin CA; Curtin NJ
Clin Cancer Res; 2005 Dec; 11(23):8449-57. PubMed ID: 16322308
[TBL] [Abstract][Full Text] [Related]
23. Abortive activity of Topoisomerase I: a challenge for genome integrity?
Jakobsen KP; Andersen AH; Bjergbæk L
Curr Genet; 2019 Oct; 65(5):1141-1144. PubMed ID: 31049660
[TBL] [Abstract][Full Text] [Related]
24. Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cells.
Das SK; Rehman I; Ghosh A; Sengupta S; Majumdar P; Jana B; Das BB
Nucleic Acids Res; 2016 Sep; 44(17):8363-75. PubMed ID: 27466387
[TBL] [Abstract][Full Text] [Related]
25. Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells.
Zellweger R; Dalcher D; Mutreja K; Berti M; Schmid JA; Herrador R; Vindigni A; Lopes M
J Cell Biol; 2015 Mar; 208(5):563-79. PubMed ID: 25733714
[TBL] [Abstract][Full Text] [Related]
26. PARP-3 is a mono-ADP-ribosylase that activates PARP-1 in the absence of DNA.
Loseva O; Jemth AS; Bryant HE; Schüler H; Lehtiö L; Karlberg T; Helleday T
J Biol Chem; 2010 Mar; 285(11):8054-60. PubMed ID: 20064938
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes.
Furuta T; Takemura H; Liao ZY; Aune GJ; Redon C; Sedelnikova OA; Pilch DR; Rogakou EP; Celeste A; Chen HT; Nussenzweig A; Aladjem MI; Bonner WM; Pommier Y
J Biol Chem; 2003 May; 278(22):20303-12. PubMed ID: 12660252
[TBL] [Abstract][Full Text] [Related]
28. Camptothecin-sensitive relaxation of supercoiled DNA by the topoisomerase I-like activity associated with poly(ADP-ribose) polymerase-1.
Yung TM; Parent M; Ho EL; Satoh MS
J Biol Chem; 2004 Mar; 279(12):11992-9. PubMed ID: 14715657
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of BLM, dissociation from topoisomerase IIIalpha, and colocalization with gamma-H2AX after topoisomerase I-induced replication damage.
Rao VA; Fan AM; Meng L; Doe CF; North PS; Hickson ID; Pommier Y
Mol Cell Biol; 2005 Oct; 25(20):8925-37. PubMed ID: 16199871
[TBL] [Abstract][Full Text] [Related]
30. Trapping of DNA topoisomerase I on nick-containing DNA in cell free extracts of Saccharomyces cerevisiae.
Lebedeva N; Auffret Vander Kemp P; Bjornsti MA; Lavrik O; Boiteux S
DNA Repair (Amst); 2006 Jul; 5(7):799-809. PubMed ID: 16713756
[TBL] [Abstract][Full Text] [Related]
31. Mycoplasma fermentans inhibits the activity of cellular DNA topoisomerase I by activation of PARP1 and alters the efficacy of its anti-cancer inhibitor.
Afriat R; Horowitz S; Priel E
PLoS One; 2013; 8(8):e72377. PubMed ID: 24013388
[TBL] [Abstract][Full Text] [Related]
32. Antisense transcripts enhanced by camptothecin at divergent CpG-island promoters associated with bursts of topoisomerase I-DNA cleavage complex and R-loop formation.
Marinello J; Chillemi G; Bueno S; Manzo SG; Capranico G
Nucleic Acids Res; 2013 Dec; 41(22):10110-23. PubMed ID: 23999093
[TBL] [Abstract][Full Text] [Related]
33. Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes.
Patel AG; Flatten KS; Schneider PA; Dai NT; McDonald JS; Poirier GG; Kaufmann SH
J Biol Chem; 2012 Feb; 287(6):4198-210. PubMed ID: 22158865
[TBL] [Abstract][Full Text] [Related]
34. Nascent DNA Proteomics Reveals a Chromatin Remodeler Required for Topoisomerase I Loading at Replication Forks.
Ribeyre C; Zellweger R; Chauvin M; Bec N; Larroque C; Lopes M; Constantinou A
Cell Rep; 2016 Apr; 15(2):300-9. PubMed ID: 27050524
[TBL] [Abstract][Full Text] [Related]
35. Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks.
Avemann K; Knippers R; Koller T; Sogo JM
Mol Cell Biol; 1988 Aug; 8(8):3026-34. PubMed ID: 2850477
[TBL] [Abstract][Full Text] [Related]
36. Delocalization of nucleolar poly(ADP-ribose) polymerase-1 to the nucleoplasm and its novel link to cellular sensitivity to DNA damage.
Rancourt A; Satoh MS
DNA Repair (Amst); 2009 Mar; 8(3):286-97. PubMed ID: 19144573
[TBL] [Abstract][Full Text] [Related]
37. DNA repair and resistance to topoisomerase I inhibitors: mechanisms, biomarkers and therapeutic targets.
Alagoz M; Gilbert DC; El-Khamisy S; Chalmers AJ
Curr Med Chem; 2012; 19(23):3874-85. PubMed ID: 22788763
[TBL] [Abstract][Full Text] [Related]
38. Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae.
Pouliot JJ; Robertson CA; Nash HA
Genes Cells; 2001 Aug; 6(8):677-87. PubMed ID: 11532027
[TBL] [Abstract][Full Text] [Related]
39. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
Wong ML; Hsu MT
J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
[TBL] [Abstract][Full Text] [Related]
40. Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair.
Löser DA; Shibata A; Shibata AK; Woodbine LJ; Jeggo PA; Chalmers AJ
Mol Cancer Ther; 2010 Jun; 9(6):1775-87. PubMed ID: 20530711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
